Skin antisepsis, oral cleansing, nasal antisepsis

Manufacturer
Sage Products LLC
Effective date
2019-05-29
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:59:34

Label at a glance#

ProductSkin antisepsis, oral cleansing, nasal antisepsis
Active ingredientCHLORHEXIDINE GLUCONATE, POVIDONE-IODINE
Label structure21 sections

Indications and uses

Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine Gluconate Oral Rinse has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and peri...

Dosage and administration

Chlorhexidine Gluconate Oral Rinse therapy should be initiated directly following a dental prophylaxis. Patients using Chlorhexidine Gluconate Oral Rinse should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 15 mL of undiluted Chlorhexidine Gluconate Oral Rin...

Label contents#

Full prescribing information#

CHLORHEXIDINE GLUCONTATE 0.12% ORAL RINSE DESCRIPTION

DESCRIPTION SECTION

Chlorhexidine Gluconate is an oral rinse containing 0.12% chlorhexidine gluconate (1,11-hexamethylene bis[5-(p-chlorophenyl) biguanide] di-D-gluconate) in a base containing water, 11.6% alcohol, glycerin, PEG-40 sorbitan diisostearate, flavor, sodium saccharin, and FD&C Blue No. 1. Chlorhexidine Gluconate is a near-neutral solution (pH range 5-7). Chlorhexidine Gluconate is a salt of chlorhexidine and gluconic acid. Its chemical structure is: Chlorhexidine Gluconate StructureChlorhexidine Gluconate Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Chlorhexidine Gluconate Oral Rinse provides antimicrobial activity during oral rinsing. The clinical significance of Chlorhexidine Gluconate Oral Rinse’s antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general reduction of counts of certain assayed bacteria, both aerobic and anaerobic, ranging from 54-97% through six months use.

Use of Chlorhexidine Gluconate Oral Rinse in a six month clinical study did not result in any significant changes in bacterial resistance, overgrowth of potentially opportunistic organisms or other adverse changes in the oral microbial ecosystem. Three months after Chlorhexidine Gluconate Oral Rinse was discontinued, the number of bacteria in plaque had returned to baseline levels and resistance of plaque bacteria to chlorhexidine gluconate was equal to that at baseline.

PHARMACOKINETICS

PHARMACOKINETICS SECTION

Pharmacokinetic studies with Chlorhexidine Gluconate Oral Rinse indicate approximately 30% of the active ingredient, chlorhexidine gluconate, is retained in the oral cavity following rinsing. This retained drug is slowly released in the oral fluids. Studies conducted on human subjects and animals demonstrate chlorhexidine gluconate is poorly absorbed from the gastrointestinal tract. The mean plasma level of chlorhexidine gluconate reached a peak of 0.206 mcg/g in humans 30 minutes after they ingested a 300 mg dose of the drug. Detectable levels of chlorhexidine gluconate were not present in the plasma of these subjects 12 hours after the compound was administered. Excretion of chlorhexidine gluconate occurred primarily through the feces (~90%). Less than 1% of the chlorhexidine gluconate ingested by these subjects was excreted in the urine.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine Gluconate Oral Rinse has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Chlorhexidine Gluconate Oral Rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients.

WARNINGS

WARNINGS SECTION

The effect of Chlorhexidine Gluconate Oral Rinse on periodontitis has not been determined. An increase in supragingival calculus was noted in clinical testing in Chlorhexidine Gluconate Oral Rinse users compared with control users. It is not known if Chlorhexidine Gluconate Oral Rinse use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Anaphylaxis, as well as serious allergic reactions, have been reported during postmarketing use with dental products containing chlorhexidine, see CONTRAINDICATIONS.

PRECAUTIONS

PRECAUTIONS SECTION

GENERAL

GENERAL PRECAUTIONS SECTION

  1. For patients having coexisting gingivitis and periodontitis, the presence or absence of gingival inflammation following treatment with Chlorhexidine Gluconate Oral Rinse should not be used as a major indicator of underlying periodontitis.
  2. Chlorhexidine Gluconate Oral Rinse can cause staining of oral surfaces, such as tooth surfaces, restorations, and the dorsum of the tongue. Not all patients will experience a visually significant increase in toothstaining. In clinical testing, 56% of Chlorhexidine Gluconate Oral Rinse users exhibited a measurable increase in facial anterior stain, compared to 35% of control users after six months; 15% of Chlorhexidine Gluconate Oral Rinse users developed what was judged to be heavy stain, compared to 1% of control users after six months. Stain will be more pronounced in patients who have heavier accumulations of unremoved plaque. Stain resulting from use of Chlorhexidine Gluconate Oral Rinse does not adversely affect health of the gingivae or other oral tissues. Stain can be removed from most tooth surfaces by conventional professional prophylactic techniques. Additional time may be required to complete the prophylaxis. Discretion should be used when prescribing to patients with anterior facial restorations with rough surfaces or margins. If natural stain cannot be removed from these surfaces by a dental prophylaxis, patients should be excluded from Chlorhexidine Gluconate Oral Rinse treatment if permanent discoloration is unacceptable. Stain in these areas may be difficult to remove by dental prophylaxis and on rare occasions may necessitate replacement of these restorations.
  3. Some patients may experience an alteration in taste perception while undergoing treatment with Chlorhexidine Gluconate Oral Rinse. Rare instances of permanent taste alteration following Chlorhexidine Gluconate Oral Rinse use have been reported via post-marketing product surveillance.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The most common side effects associated with chlorhexidine gluconate oral rinses are: 1) an increase in staining of teeth and other oral surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception; see WARNINGS and PRECAUTIONS. Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate rinse. The following oral mucosal side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1%. Among post marketing reports, the most frequently reported oral mucosal symptoms associated with Chlorhexidine Gluconate Oral Rinse are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia. Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using Chlorhexidine Gluconate Oral Rinse. There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadenitis) reported in patients using Chlorhexidine Gluconate Oral Rinse.

OVERDOSAGE

OVERDOSAGE SECTION

Ingestion of 1 or 2 ounces of Chlorhexidine Gluconate Oral Rinse by a small child (~10 kg body weight) might result in gastric distress, including nausea, or signs of alcohol intoxication. Medical attention should be sought if more than 4 ounces of Chlorhexidine Gluconate Oral Rinse is ingested by a small child or if signs of alcohol intoxication develop.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Chlorhexidine Gluconate Oral Rinse therapy should be initiated directly following a dental prophylaxis. Patients using Chlorhexidine Gluconate Oral Rinse should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 15 mL of undiluted Chlorhexidine Gluconate Oral Rinse. Patients should be instructed to not rinse with water, or other mouthwashes, brush teeth, or eat immediately after using Chlorhexidine Gluconate Oral Rinse. Chlorhexidine Gluconate Oral Rinse is not intended for ingestion and should be expectorated after rinsing.

HOW SUPPLIED

HOW SUPPLIED SECTION

Chlorhexidine Gluconate Oral Rinse is supplied as a blue liquid in single dose 0.5 fluid ounce (15mL) amber plastic bottles with child-resistant dispensing closures. STORE at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP controlled room temperature].

SPL PATIENT PACKAGE INSERT SECTION

Rx only. KEEP OUT OF REACH OF CHILDREN.

WHAT TO EXPECT WHEN USING CHLORHEXIDINE GLUCONATE ORAL RINSE
Your dentist has prescribed Chlorhexidine Gluconate Oral Rinse to treat your gingivitis, to help reduce the redness, and swelling of your gums, and also to help you control any gum bleeding. Use Chlorhexidine Gluconate Oral Rinse regularly, as directed by your dentist, in addition to daily brushing. Spit out after use. Chlorhexidine Gluconate Oral Rinse should not be swallowed.

If you develop allergic symptoms such as skin rash, itch, generalized swelling, breathing difficulties, light headedness, rapid heart rate, upset stomach or diarrhea, seek medical attention immediately. Chlorhexidine Gluconate Oral Rinse should not be used by persons who have a sensitivity to it or its components.

Chlorhexidine Gluconate Oral Rinse may cause some tooth discoloration, or increase in tartar (calculus) formation, particularly in areas where stain and tartar usually form. It is important to see your dentist for removal of any stain or tartar at least every six months or more frequently if your dentist advises.

Both stain and tartar can be removed by your dentist or hygienist. Chlorhexidine Gluconate Oral Rinse may cause permanent discoloration of some front-tooth fillings.
To minimize discoloration, you should brush and floss daily, emphasizing areas which begin to discolor.
Chlorhexidine Gluconate Oral Rinse may taste bitter to some patients and can affect how foods and beverages taste. This will become less noticeable in most cases with continued use of Chlorhexidine Gluconate Oral Rinse.
To avoid taste interference, rinse with Chlorhexidine Gluconate Oral Rinse after meals. Do not rinse with water or other mouthwashes immediately after rinsing with Chlorhexidine Gluconate Oral Rinse.
If you have any questions or comments about Chlorhexidine Gluconate Oral Rinse, contact your dentist or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

INGREDIENTS: 0.12% chlorhexidine gluconate in a base containing water, 11.6% alcohol, glycerin, PEG-40 sorbitan diisostearate, flavor, sodium saccharin, and FD&C Blue No. 1.

STORE at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP controlled room temperature].

Manufactured for:
Sage Products LLC
Cary, IL 60013

1-800-323-2220

Revised: October, 2018

SAGE15ORBTLLBLB

2% CHLORHEXIDINE GLUCONATE CLOTH

OTC - ACTIVE INGREDIENT SECTION

Active IngredientPurpose
 Chlorhexidine Gluconate 2% Solution Antiseptic

USES

INDICATIONS & USAGE SECTION

  • helps reduce bacteria that can potentially cause skin infection
  • for preparation of skin prior to surgery

WARNINGS

WARNINGS SECTION

For external use only

Allergy alert:

This product may cause a severe allergic reaction. Symptoms may include:

  • wheezing/difficulty breathing
  • shock
  • facial swelling
  • hives
  • rash

If an allergic reaction occurs, stop use and seek medical help right away.

Do not use

  • on patients allergic to chlorhexidine gluconate or any other ingredient in this product
  • for lumbar punctures or in contact with the meninges
  • on open skin wounds or as a general skin cleanse

When using this product

  • keep out of eyes, ears and mouth. May cause serious or permanent injury if chlorhexidine is permitted to enter and remain. If contact occurs, rinse with cold water right away and contact a doctor.

Stop use and ask a doctor if irritation, sensitization or allergic reaction occurs. These may be signs of a serious condition.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.
  • do not microwave
  • product and packaging are not sterile. Follow your hospital policy for skin preparation with non-sterile products.

To open package

  • holding top of package in one hand, lift flap on backside of package with other hand
  • grasp flap at top and pull down to tear flap away and expose foam
  • hold outside of package to present foam and cloths to prep table, avoiding contact between cloths and outside of package to reduce risk of cloth contamination

Or

  • using sterile scissors, cut off end seal of package
  • transfer contents onto prep table, avoiding contact between cloths and outside of package to reduce risk of cloth contamination
  • use first cloth to prepare the skin area indicated for a moist or dry site, making certain to keep the second cloth where it will not be contaminated. Use second cloth to prepare larger areas.
  • dry surgical sites (such as abdomen or arm): use one cloth to cleanse each 161 cm2 area (approximately 5 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard. Allow area to air dry for one (1) minute. Do not rinse.
  • moist surgical sites (such as inguinal fold): use one cloth to cleanse each 65 cm2 area (approximately 2 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard. Allow area to air dry for one (1) minute. Do not rinse.
  • discard each cloth after a single use
  • after package has been opened discard any unused cloths

Other information

  • store product flat
  • store between 20-25°C (68-77°F)
  • avoid excessive heat above 40°C (104°F)

INACTIVE INGREDIENT SECTION

aloe vera, dimethicone, fragrance, glucono-delta-lactone, glycerin, Igepal®, polysorbate 20, propylene glycol, USP purified water

cloth: polyester

QUESTIONS OR COMMENTS?

OTC - QUESTIONS SECTION

call toll-free 800-323-2220

(Monday to Friday 8 AM - 5 PM CST)

www.sageproducts.com

SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

9011 BAG LABEL9011 BAG LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

9707 CLOTH LABEL9707 CLOTH LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0.12% CHG ORAL RINSE0.12% CHG ORAL RINSE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
834127chlorhexidine gluconate 0.12 % Oral RinsePSN3
846127chlorhexidine gluconate 2 % Medicated PadPSN3
252965povidone-iodine 5 % Topical SolutionPSN3
834127chlorhexidine gluconate 1.2 MG/ML MouthwashSCD3
846127chlorhexidine gluconate 20 MG/ML Medicated PadSCD3
252965povidone-iodine 50 MG/ML Topical SolutionSCD3
834127chlorhexidine gluconate 0.12 % MouthwashSY3
834127chlorhexidine gluconate 0.12 % Oral RinseSY3
846127chlorhexidine gluconate 2 % Medicated PadSY3
252965povidone-iodine 5 % (titratable iodine 0.5 % ) Topical SolutionSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORHEXIDINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53462-007-272021-01-29C16284748780-1ba0f9c33-4faf-a910-e053-dadaa90a0b85Skin Antisepsis, oral cleansing, nasal antisepsis

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53462-003-15Skin antisepsis, oral cleansing, nasal antisepsis15 mL in 1 BOTTLELIQUID15 mL1.2 mg in 1mL3
53462-007-27Skin antisepsis, oral cleansing, nasal antisepsis1 in 1 KITKIT13
53462-705-23Skin antisepsis, oral cleansing, nasal antisepsis6 in 1 PACKAGECLOTH6500 mg3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53462-003SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS LLC]3Current NDC, Legacy NDC20190530_6ea1691d-5379-f0c0-1b37-ecf08f6dbc00.zip
53462-007SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS LLC]3Legacy NDC, 3 package rows20190530_6ea1691d-5379-f0c0-1b37-ecf08f6dbc00.zip
53462-705SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS LLC]3Current NDC, Legacy NDC20190530_6ea1691d-5379-f0c0-1b37-ecf08f6dbc00.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
53462-705-20EA - Each53462-70507f8a3cf-9379-4359-bae1-02cecd93793c12012-07-24
53462-705-23EA - Each53462-7053d90eac6-c72f-4444-b4d0-c4ea1b1b88f012012-07-24
53462-705-26EA - Each53462-7058ee590b2-e855-4f04-8861-4ed0d0b878fc12024-04-05
17518-060-04EA - Each17518-06087da09da-00f8-4da0-aca0-5f3802b38dbc12024-04-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
chlorhexidine gluconateACTIVE INGREDIENTMOR84MUD8E1
POVIDONE-IODINEACTIVE INGREDIENT85H0HZU99M1
chlorhexidineACTIVE MOIETYR4KO0DY52L1
IODINEACTIVE MOIETY9679TC07X41
ALCOHOLINACTIVE INGREDIENT3K9958V90M1
aloe vera leafINACTIVE INGREDIENTZY81Z83H0X1
dimethicone 350INACTIVE INGREDIENT2Y53S6ATLU1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD1
gluconolactoneINACTIVE INGREDIENTWQ29KQ9POT1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
LACTIC ACIDINACTIVE INGREDIENT33X04XA5AT1
LAURAMIDOPROPYLAMINE OXIDEINACTIVE INGREDIENTI6KX160QTV1
MALIC ACIDINACTIVE INGREDIENT817L1N4CKP1
nonoxynol-9INACTIVE INGREDIENT48Q180SH9T1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999R1
PEG-40 SORBITAN DIISOSTEARATEINACTIVE INGREDIENTJL4CCU7I1G1
polysorbate 20INACTIVE INGREDIENT7T1F30V5YH1
propylene glycolINACTIVE INGREDIENT6DC9Q167V31
SACCHARIN SODIUM DIHYDRATEINACTIVE INGREDIENTSB8ZUX40TY1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
SODIUM IODIDEINACTIVE INGREDIENTF5WR8N145C1
waterINACTIVE INGREDIENT059QF0KO0R1
XYLITOLINACTIVE INGREDIENTVCQ006KQ1E1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53462-00753462-007-27
53462-70553462-705-23
17518-060
53462-00353462-003-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 52 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / TOPICAL39 mgExact identifier — unii+route+dosage form
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYSOLUTION / RESPIRATORY (INHALATION)NAExact identifier — unii+dosage form
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYOINTMENT / TOPICALNAExact identifier — unii+route
15 equally ranked IID candidates
nonoxynol-9NONOXYNOL-948Q180SH9TCLOTH / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESOLUTION / ORAL21600 mgExact identifier — unii+dosage form
3 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
6 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
6 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATSOLUTION / TOPICAL7.22 %w/wExact identifier — unii+route+dosage form
gluconolactoneGLUCONOLACTONEWQ29KQ9POTSOLUTION / TOPICAL0.3 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
6 equally ranked IID candidates
PEG-40 SORBITAN DIISOSTEARATEPEG-40 SORBITAN DIISOSTEARATEJL4CCU7I1GLIQUID / ORAL20 mgExact identifier — unii+dosage form
3 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYFILM / BUCCAL3 mgExact identifier — unii+route
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYFILM, SOLUBLE / BUCCAL2 mgExact identifier — unii+route
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYFILM, SOLUBLE / BUCCAL2 mgExact identifier — unii+route
15 equally ranked IID candidates
PEG-40 SORBITAN DIISOSTEARATEPEG-40 SORBITAN DIISOSTEARATEJL4CCU7I1GLIQUID / ORAL20 mgExact identifier — unii+dosage form
3 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYTABLET / BUCCAL0.4 mgExact identifier — unii+route
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYLIQUID / ORAL3 mgExact identifier — unii+dosage form
15 equally ranked IID candidates
MALIC ACIDMALIC ACID817L1N4CKPSOLUTION / ORAL16760 mgExact identifier — unii+dosage form
PEG-40 SORBITAN DIISOSTEARATEPEG-40 SORBITAN DIISOSTEARATEJL4CCU7I1GSOLUTION / DENTAL0.8 %w/vExact identifier — unii+dosage form
3 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYFILM / BUCCAL3 mgExact identifier — unii+route
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EGUM, CHEWING / BUCCAL11915 mgExact identifier — unii+route
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYOINTMENT / TOPICALNAExact identifier — unii+route
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYTABLET / BUCCAL0.4 mgExact identifier — unii+route
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EGUM, CHEWING / BUCCAL11915 mgExact identifier — unii+route
3 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSOLUTION / TOPICAL0.01 %w/wExact identifier — unii+route+dosage form
polysorbate 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUCLOTH / TOPICALNAExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYSOLUTION / DENTAL0.05 %w/vExact identifier — unii+dosage form
15 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
6 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TOPICAL2445 mgExact identifier — unii+route+dosage form
nonoxynol-9NONOXYNOL-948Q180SH9TCLOTH / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYOINTMENT / TOPICALNAExact identifier — unii+route
15 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYSOLUTION / ORAL665 mgExact identifier — unii+dosage form
15 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYLIQUID / ORAL3 mgExact identifier — unii+dosage form
15 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
3 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
6 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SACCHARIN SODIUM DIHYDRATESACCHARIN SODIUMSB8ZUX40TYSOLUTION / RECTAL665 mgExact identifier — unii+dosage form
15 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUSOLUTION / TOPICAL0.5 %w/wExact identifier — unii+route+dosage form
3 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
3 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
6 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 2 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077789-001CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A077789-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1884e616aacf4f…
2026-08-18 06:07:402026-07A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-188072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-185c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-185d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-184b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-1887673890dc5c…
2021-03-12 10:30 UTC2021-03A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-185aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-188869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-183f01610625f2…
2019-09-15 20:21 UTC2019-09A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18b00525d2431f…
2019-07-19 19:46 UTC2019-07A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-186a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-181c564ffb4f44…
2023-12-20 04:57 UTC2023-12A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-189b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-183f0d92c62455…
2023-05-13 08:27 UTC2023-05A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18053a50430f4f…
2023-01-26 05:58 UTC2023-01A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-183bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-183a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A077789-001CHLORHEXIDINE GLUCONATE0.12%SOLUTION / DENTALAT2009-06-18f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A077789-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A077789-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077789-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077789-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A077789-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077789-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077789-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077789-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077789-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077789-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077789-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077789-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077789-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077789-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077789-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077789-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077789-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077789-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077789-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077789-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077789-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A077789-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077789-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A077789-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077789-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077789-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077789-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A077789-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A077789-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A077789-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A077789-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A077789-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A077789-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A077789-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A077789-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A077789-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A077789-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A077789-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077789-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A077789-001AT1f41ea6bd6efb…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021669-001CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021669-00174275742026-04-25Drug product
N021669-00179350932027-10-02U-1022Drug product2011-05-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2584e616aacf4f…
2026-08-18 06:07:402026-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2531067a03dcf5…
2025-08-23 18:47 UTC2025-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-256a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-252680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-251e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-258072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-254b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2587673890dc5c…
2021-03-12 10:30 UTC2021-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-258869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253f01610625f2…
2019-09-15 20:21 UTC2019-09N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25b00525d2431f…
2019-07-19 19:46 UTC2019-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-256a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-251c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-259b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253f0d92c62455…
2023-05-13 08:27 UTC2023-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25053a50430f4f…
2023-01-26 05:58 UTC2023-01N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25f41ea6bd6efb…

Observed Orange Book patent history#

Patent history page 1 of 5 · 184 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N021669-00174275742026-04-25Drug product84e616aacf4f…
2026-09-14 22:38:342026-08N021669-00179350932027-10-02U-1022Drug product2011-05-2484e616aacf4f…
2026-08-18 06:07:402026-07N021669-00174275742026-04-25Drug productcaaa826d4ba7…
2026-08-18 06:07:402026-07N021669-00179350932027-10-02U-1022Drug product2011-05-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021669-00174275742026-04-25Drug product011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021669-00179350932027-10-02U-1022Drug product2011-05-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00177178892025-02-27U-1022Drug product2012-05-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00174275742026-04-25Drug product31067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00179350932027-10-02U-1022Drug product2011-05-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N021669-00177178892025-02-27U-1022Drug product2012-05-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021669-00174275742026-04-25Drug product6a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021669-00179350932027-10-02U-1022Drug product2011-05-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00177178892025-02-27U-1022Drug product2012-05-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00174275742026-04-25Drug productfd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00179350932027-10-02U-1022Drug product2011-05-24fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00177178892025-02-27U-1022Drug product2012-05-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00174275742026-04-25Drug productb8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00179350932027-10-02U-1022Drug product2011-05-24b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00170669162024-02-17U-73703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00177178892025-02-27U-1022Drug product2012-05-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00174275742026-04-25Drug product03ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00179350932027-10-02U-1022Drug product2011-05-2403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00170669162024-02-17U-7372680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00177178892025-02-27U-1022Drug product2012-05-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00174275742026-04-25Drug product2680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00179350932027-10-02U-1022Drug product2011-05-242680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00170669162024-02-17U-7375bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00177178892025-02-27U-1022Drug product2012-05-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00174275742026-04-25Drug product5bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00179350932027-10-02U-1022Drug product2011-05-245bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00170669162024-02-17U-737d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00177178892025-02-27U-1022Drug product2012-05-25d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00174275742026-04-25Drug productd8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00179350932027-10-02U-1022Drug product2011-05-24d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021669-00170669162024-02-17U-737d06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00177178892025-02-27U-1022Drug product2012-05-25d06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00174275742026-04-25Drug productd06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00179350932027-10-02U-1022Drug product2011-05-24d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-00170669162024-02-17U-73779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-00177178892025-02-27U-1022Drug product2012-05-2579d66fd596c7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATESage Products LLCbdb6a012-37e5-4664-84a3-134bea2847442026-06-16WarningsExact identifier
ndc (package): 53462-705-23
ndc (product): 53462-705
ndc11 (package): 53462070523
3M Skin and Nasal AntisepticPOVIDONE-IODINESolventum US LLC1a94494d-7dd3-4f32-bc42-81c199fe233e2026-04-22WarningsExact identifier
ndc (product): 17518-060
Chlorhexidine Gluconate 0.12% Oral RinseCHLORHEXIDINE GLUCONATESage Products LLC3c754532-d9a5-f876-00c4-05a4c9b21efa2025-10-21Warnings, Adverse reactionsExact identifier
ndc (package): 53462-003-15
ndc (product): 53462-003
ndc11 (package): 53462000315
8a0dae43-bec9-3b38-e053-2a95a90a236b6ea1691d-5379-f0c0-1b37-ecf08f6dbc002019-05-29Warnings, Adverse reactionsExact identifier
spl id: 8a0dae43-bec9-3b38-e053-2a95a90a236b
spl set id: 6ea1691d-5379-f0c0-1b37-ecf08f6dbc00

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.